disorders [2] . The prevalence of obesity and dyslipidemia is on the rise throughout the world every year [3] . Obesity is a chronic disease [4] that occurs due to the imbalance between energy intake and energy consumption [5] . Over the years, many treatments have been introduced to manage dyslipidemia and obesity, including statins, HMG-CoA reductase inhibitors, as well as niacin as a lipase inhibitor in the adipose tissue, omega-3 fatty acid, and fibrates [6] [7] [8] .
Orlistat is currently one of the medicines approved by the Food and Drug Administration for the treatment of obesity, with the commercial brand of Xenical, which acts as a potent, specific, and irreversible inhibitor of pancreatic and gastrointestinal carboxyl ester lipase [9] [10] [11] . However, it has an unpleasant effect on the gastrointestinal tract (steatorrhea) [10] . Evidence has revealed that medicinal plants, such as fenugreek can decrease the incidence rate of various diseases and play an important role in the management of dyslipidemia and obesity as well as associated complications through exerting protective effects on the oxidative damage and reducing inflammation; besides, it can be a suitable alternative for chemical drugs [12, 13] .
Fenugreek (Trigonella foenum-graecum) is an annual plant in the family of Leguminosae [14] . It is native to the eastern shores of the Mediterranean and North Africa. According to some researchers, fenugreek was initially native to Iran and then distributed to other regions [15] . The chemical composition of this plant consists of diosgenin, 4-OH-Ile, fiber [16] , galactomannan [17] , terpenes [18] , trigonellin, sapogenins, and mucilage [19] . Based on past research, the long-term use of fenugreek controls appetite and helps in the treatment of obesity [20] [21] [22] [23] . Other studies have shown that the use of the fenugreek seed extract leads to a decrease in the blood glucose, total cholesterol, triglycerides, and low density lipoprotein in types 栺 and 栻 diabetes mellitus [24] [25] [26] . Studies have shown that diosgenin [(25R)-5-Spirosten-3 毬 -ol, 3 毬 -Hydroxy-5-spirostene], (2S, 3R)-2-Amino-4-hydroxy-3-methylpentanoic acid, and 4-OH-Ile are the bioactive compounds present in the fenugreek plant. Diosgenin is a bioactive steroidal saponin in fenugreek [27] , and 4-OH-Ile is a branched-chain amino acid found in fenugreek seeds [28] . Diosgenin is known as a lipid-lowering, anti-diabetes, anti-cancer, and antioxidative stress agent [16] . In addition, 4-OH-Ile plays a significant role in the improvement of dyslipidemia, diabetes, obesity, and metabolic syndrome [16, 29] .
The present study explored the alteration of vital genes, including low-density lipoprotein receptor (LDLR), liver X receptor alpha (LXR 毩 ), sterol regulatory element-binding protein-1C (SREBP-1C), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), peroxisome proliferator-activated receptor gamma (PPAR 毭 ), and fibroblast growth factor 21 (FGF21) in the HepG2 cell line, involved in lipid metabolism. In this study, apart from the hydroalcoholic fenugreek seed extract (HFSE), the effects of diosgenin and 4-OHIle, as the two major components of fenugreek seeds, were compared with orlistat as a most common hypolipidemic drug.
Materials and methods

Materials
The HepG2 cell line was purchased from the Pasteur Institute (Iran, Tehran). The materials required for cell culture included RPMI-1640, fetal bovine serum, penicillin-streptomycin and trypsin enzymes from Gibco-BRL (Grand Island, NY, USA), dimethyl sulfoxide (DMSO) from Merck (USA), MTT powder, diosgenin with the purity of 93%, 4-OH-Ile with the purity of ≥ 98% (TLC), orlistat with the purity of ≥ 98% from Sigma (Sigma-Aldrich, USA), the RNA extraction and cDNA synthesis kit purchased from PARS Tous (Iran), and the SYBR Green Premix Ex Taq 栻 Kit (Takara, Japan), which were all prepared. The extraction process was performed using a Soxhlet extractor (BAKHSHI Laboratory Industrial Co., Iran). Next, 5 grams of the powder were weighed, poured in a paper filter, and placed in the specific part of the device embedded inside the beakers. Two thirds of the beakers were then filled with 70% ethanol and placed in a specific part of the device. The solution started boiling at 80 曟 for 100 min to deposit a concentrated solution at the bottom of the container. In the next step, the resulting solution was poured in sterilized petri dishes that were placed in a freeze dryer (model: VaCo5-D, Zirbus Technology Co., Germany) at -70 曟 for 72 h until it turned into a dry yellow and crystalline powder. The extract powder was kept in a freezer at -20 曟 . Other concentrations of the extract were obtained by RPMI 1640.
Preparation of HFSE
Preparation of diosgenin, 4-OH-Ile, and orlistat
Stock solutions were prepared from diosgenin in ethanol [30] , 4-OHIle in phosphate buffered saline (PBS) [31] , and orlistat dissolved in the sterile DMSO [32] .
Cell culture
The liver and hepatocytes play an important role in fat metabolism, since the production of lipids and oxidation of fatty acids occur in them. The HepG2 cell line is suitable for the study of fat metabolism in the liver. Thus, in this study, HepG2 cells were cultured in the RPMI 1640 culture medium containing 10% FBS, 100 IU/mL of penicillin, and 100 g/mL of streptomycin, and then incubated at 37 曟 at the presence of 5% CO 2 and 95% humidity. When the cell density reached 70%-80%, the treatment would proceed at the different concentrations of HFSE, diosgenin, 4-OH-Ile, and orlistat for 24 and 48 h.
Cell viability assay
The MTT assay, as a direct colorimetric reaction, was used to study cytotoxic effects and determine the IC 50 Diethyl pyrocarbonate solution was used as the blank. The RNA purity was assessed by measuring the absorbance ratio of 260/280 nm, with the OD ratio being between 1.8 and 2 for all samples.
The intergrity of RNA was also determined by 1.2% agarose gel electrophoresis. cDNA was synthesized using the Pars Tous Kit, according to the manufacturer's protocol. A total of 3-5 μg of pure mRNA, oligo dT, random hexamer, and reverse transcriptase enzymes were used to synthesize cDNA [35] .
Real time PCR
To determine the expression alteration of the genes LDLR, LXR毩, SREBP-1C, ACC, FAS, FGF21, and PPAR毭, the real time PCR technique was used. The real time PCR process was followed using specific primers in triplicate. The specificity of the primers designed for each gene was controlled on the basis of BLAST on the NCBI site ( Table 1 ). The To estimate the fold change of the genes studied, the threshold cycle (CT) data were analyzed by the software Step One ver. 
Results
Effects of HFSE, its active components, and orlistat on cell viability
The cell viability percentage decreased in a dose-dependent manner 3 Moreover, the 48-hour results showed a significant difference in FGF21
gene between HFSE and diosgenin groups (P=0.010) ( Table 2) . 
Discussion
Dyslipidemias are commonly known as multifactorial diseases [38] .
In fact, disorder of triglyceride and the cholesterol metabolism results in the abnormal levels of plasma lipids that are the causes of a pathologic state called dyslipidemia. Recent studies have shown a significant relationship between dyslipidemia and obesity [39] . The prevalence of overweight and obesity is increasing at an alarming rate in all societies and age groups around the world. Overweight and obesity are the two major causes of diseases and mortality, which can be prevented [40] .
They lead to weight-related diseases and a decrease in the quality of life [41] . The risk of developing diseases such as arthritis, lung diseases, type 2 diabetes, insulin resistance, metabolic syndrome, hypertension, hyperlipidemia, thromboembolism, infertility, coronary heart disease, and the heart failure increases due to overweight and obesity [41, 42] . Cholesterol homeostasis is regulated at the transcriptional level by LXR 毩 [45] . LXR毩 is a nuclear transcription factor that regulates lipid expression by regulating a lipogenic transcription factor (SREBP-1C) [46] . It plays a significant role in inducing lipogenic genes in the liver, both through a direct activity to increase the expression of the genes ACC and FAS, or indirectly by increasing the expression of SREBP-1 [47] . In the present study, it was observed that HFSE, These results are partly confirmed by Khound and colleagues [50] .
They reported that dietary fenugreek seed inhibits the liver SREBP- acid biosynthesis [50] . Therefore, in the present study, HFSE and its Moreover, following the inactivation of HMG-CoA reductase, the synthesis of cholesterol decreases [52] .
FGF21 is one of the important targets of PPAR 毭 [53] . FGF21 is expressed in the liver and regulates lipid metabolism in response to nutritional conditions [54] . Besides, FGF21 regulates liver lipolysis and the use of fatty acids [45] . It has also been shown that FGF21
has the ability to reduce body weight and low-density lipoprotein (LDL) cholesterol, and increase high-density lipoprotein levels in obese humans [55] , yet the mechanism is not fully known. A recent study revealed that the gene FGF21 had at least one LXR response element, and that there was a negative correlation between the level of expression of the gene LXR毩 and the gene FGF21 in the liver [45] .
In the present study, the treatment of HepG2 cells with HFSE, Another study reported that the aqueous extract of fenugreek seeds improved some parameters, including insulin, glucose, adiponectin, and triglyceride significantly. This study showed the positive effects of fenugreek seeds through three mechanisms, i.e. the direct insulinlike effect, the increase in the adiponectin level, and the increase in the expression of the PPAR 毭 protein [26] . Similar to previous research, the possible cause of the increase in the PPAR毭 gene in the present study was to justify that HFSE and its active ingredients could reduce the synthesis of fatty acids, increase beta-oxidation, as well as improve dyslipidemia and obesity through two pathways. In the sterol-enriched status, this extract adjusted the LDLR expression and increased LDL absorption [2] .
Finally, it can be stated that HFSE and its active ingredients 
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